OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR WITH RIBAVIRIN (RBV) HAS MINIMAL IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) COMPARED WITH PLACEBO DURING 12-WEEK TREATMENT IN TREATMENT-NAIVE ADULTS WITH CHRONIC HEPATITIS C (CHC)

被引：2

作者：

Liu, Y. ^{[1
]}

Larsen, L. ^{[1
]}

Zeuzem, S. ^{[2
]}

Coakley, E. ^{[1
]}

Baran, R. ^{[1
]}

Juday, T. ^{[1
]}

机构：

[1] Abbvie Inc, N Chicago, IL USA

[2] Wolfgang Goethe Univ Hosp, Frankfurt, Germany

来源：

关键词：

D O I：

10.1016/S0168-8278(15)31075-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P0873

引用

页码：S668 / S668

页数：1